NCT00424164View on ClinicalTrials.gov

Lapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

June 30, 2009

Study Completion Date

May 28, 2010

Conditions
Breast Cancer
Interventions
DRUG

lapatinib ditosylate

DRUG

tamoxifen citrate

OTHER

pharmacological study

Trial Locations (1)

21079

Centre Regional Rene Gauducheau, Dijon

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00424164 - Lapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter